Document is current
Any future updates will be listed below
-
Authors
Rehn, Fabian
Kraemer-Schulien, Victoria
Bujnicki, Tuyen
Bannach, Oliver
Tschoepe, Diethelm
Stratmann, Bernd
Willbold, Dieter
-
Funding
Funding for this research was provided by:
Helmholtz Association (HVF0079)
Helmholz Innovation lab (DB001822)
The Michael J. Fox Foundation for Parkinson’s Research (14977)
The Michael J. Fox Foundation for Parkinson’s Research (009889)
ALS Association and from the Packard Center (19-SI-476)
Deutsche Forschungsgemeinschaft (INST 208/616-1 FUGG)
Deutsche Forschungsgemeinschaft (INST 208/794-1 FUGG)
Forschungszentrum Jülich GmbH
- License Information
-
More Information
Article History
Received: 13 May 2024
Accepted: 14 August 2024
First Online: 22 August 2024
Competing interests
: BS has none to declare. DW and OB are co-founder and co-owner of attyloid GmbH, which is commercializing the sFIDA technology. This did not influence any data interpretation. All the remaining authors declare no conflict of interest.
